國立高雄大學圖資館 |

Language: English

Back

Breast cancer genetics, immunology, and immunotherapyan interdisciplinary approach /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Breast cancer genetics, immunology, and immunotherapyedited by Nima Rezaei.
Reminder of title:	an interdisciplinary approach /
other author:	Rezaei, Nima.
Published:	Cham :Springer Nature Switzerland :2024.
Description:	xi, 435 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	BreastCancer
Online resource:	https://doi.org/10.1007/978-3-031-65808-2
ISBN:	9783031658082$q(electronic bk.)

Breast cancer genetics, immunology, and immunotherapyan interdisciplinary approach /
Breast cancer genetics, immunology, and immunotherapyan interdisciplinary approach /[electronic resource] :edited by Nima Rezaei. - Cham :Springer Nature Switzerland :2024. - xi, 435 p. :ill. (chiefly col.), digital ;24 cm. - Interdisciplinary cancer research,v. 62731-457X ;. - Interdisciplinary cancer research ;v. 1..

Role of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment -- Approaches to Breast Cancer Immunology and Immunotherapy -- Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches -- Interleukins in the Development and Progression of Breast Cancer -- Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer -- The Prognostic Impact of Tumor-Infiltrated Lymphocytes (TILs) in Breast Cancer -- From Genes to Recovery: Precision Medicine and Its Influence on Multidrug Resistant Breast Cancer -- Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment -- Targeting Myeloid Determinants of Breast Cancer -- siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment -- Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer -- Oncolytic Virotherapy Against Breast Cancer -- Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development.

Genetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the "Interdisciplinary Cancer Research" series, entitled "Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach" publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN) This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.

ISBN: 9783031658082$q(electronic bk.)

Standard No.: 10.1007/978-3-031-65808-2doiSubjects--Topical Terms:

357478
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449

Breast cancer genetics, immunology, and immunotherapyan interdisciplinary approach /
LDR:03595nmm a2200337 a 4500 001 666513
003 DE-He213
005 20240719130219.0
006 m d
007 cr nn 008maaau
008 250107s2024 sz s 0 eng d
020 $a 9783031658082$q(electronic bk.)
020 $a 9783031658075$q(paper)
024 7 $a 10.1007/978-3-031-65808-2 $2 doi
035 $a 978-3-031-65808-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b B828 2024
245 0 0 $a Breast cancer genetics, immunology, and immunotherapy $h [electronic resource] : $b an interdisciplinary approach / $c edited by Nima Rezaei.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xi, 435 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
490 1 $a Interdisciplinary cancer research, $x 2731-457X ; $v v. 6
505 0 $a Role of miRNAs in Triple-Negative Breast Cancer: Diagnosis, Prognosis, and Treatment -- Approaches to Breast Cancer Immunology and Immunotherapy -- Molecular Genetics of Breast Cancer: From Mechanistic Insights to the Therapeutic Approaches -- Interleukins in the Development and Progression of Breast Cancer -- Shaping of the Immune Landscape by Chemokine Receptors that Impacts the Clinical Outcome in Triple-Negative Breast Cancer -- The Prognostic Impact of Tumor-Infiltrated Lymphocytes (TILs) in Breast Cancer -- From Genes to Recovery: Precision Medicine and Its Influence on Multidrug Resistant Breast Cancer -- Recent Progress and Prospects of Immunotherapy in Multidrug-Resistant and Metastatic Breast Cancer Treatment -- Targeting Myeloid Determinants of Breast Cancer -- siRNA Loaded in Drug Delivery Nanosystems as a Strategy for Breast Cancer Treatment -- Nucleic Acid and Drug Dual Agent Nanoplatforms for Breast Cancer -- Oncolytic Virotherapy Against Breast Cancer -- Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development.
520 $a Genetics have a role in the presence of breast cancer, while the potential role of the immune system leads to consideration of immunotherapy in the treatment of the disease, particularly in metastatic triple-negative breast cancer. The sixth volume of the "Interdisciplinary Cancer Research" series, entitled "Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach" publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis. The role of molecular genetics, interleukins, chemokine receptor, and tumor-infiltrated lymphocytes-TILS in breast cancer are explained. Targeting myeloid determinants, SiRNA loaded in drug delivery nanosystems, nucleic acid and drug dual agent nanoplatforms, and oncolytic virotherapy are also discussed in the treatment of breast cancer, particularly in multidrug resistant and metastatic breast cancer. This interdisciplinary series is of special value to researchers working on immunology, genetics, and practitioners working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN) This interdisciplinary book will be of special value to researchers, oncologists, geneticists, and immunologists who wish to extend their knowledge on breast cancer.
650 0 $a Breast $x Cancer $x Genetic aspects. $3 357478
650 0 $a Breast $x Cancer $x Immunological aspects. $3 979252
650 1 4 $a Cancer Biology. $3 920982
650 2 4 $a Cancer Therapy. $3 915060
650 2 4 $a Cancer Genetics and Genomics. $3 918740
650 2 4 $a Oncology. $3 195181
650 2 4 $a Tumour Immunology. $3 921116
650 2 4 $a Immunotherapy. $3 211033
700 1 $a Rezaei, Nima. $3 591948
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Interdisciplinary cancer research ; $v v. 1. $3 957848
856 4 0 $u https://doi.org/10.1007/978-3-031-65808-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)